RPG Life Sciences Limited has informed the NSE recently that the company has been granted a patent for its Novel Drug Delivery System (NDDS) in Cyclosporin formulations by the Registrar of Patents, Republic of South Africa.

This is the first of the patents to be granted in the national phase for this formulation's patent application through the Patent Co-operation Treaty route.

RPG Life manufactures bulk drugs, formulations and biotech products at its facilities in Thane and Ankleshwar. It manufactures APIs in the areas like anti-inflammatory, cough & cold, prokinetics, systemic antibiotics, other anti-infectives, at its Thane facility. The Ankleshwar facility, which received Medicines Control Authority (MCA) approval in 2002, is used to produce formulations, tablets and syrups.